BioSpace News Archive

With Canada once again debating public drug coverage, a new Conference Board of Canada report assesses different options for national pharmacare against key objectives identified earlier this year by senior health leaders.

Joule, a Canadian Medical Association (CMA) subsidiary, today announced the recipients for its annual Innovation grants.

For medical professionals, every second counts during an emergency. Their only line of defense is to stay cool, comfortable, and prepared.

NarrativeDx announced today that the US Patent Office has awarded to it a patent that covers the automated analysis of patient feedback, a cornerstone of consumerism strategies for many health systems.

According to data compiled by Verified Market Intelligence, the global marijuana market was valued at USD 42.2 Billion in 2017 and is projected to reach USD 466.81 Billion

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will present data from three accepted abstracts related to MEI Pharma’s clinical stage drug development programs at the 2018 ASH Annual Meeting to be held December 1-4, 2018 in San Diego.

Capital Square 1031, a leading sponsor of Delaware statutory trust investments, announced today that CS1031 Diversified Dialysis Portfolio, DST, comprised of nine medical office buildings in five states, has been fully subscribed by a total of 45 investors.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced their CEO, Eyal Barad, will speak on a panel at the Marijuana Business Conference

Through a new $21 Million, Four-Year Investment, Amgen Scholars Program to Reach Additional 1,500 Undergraduates

Medela’s negative pressure wound therapy (NPWT) product line on a national basis.